GlassScriptPhysician profile
Jamie B Varney
NPI 1679787493
$1,572.36
in general payments reported to CMS, 2019-2025
33 companies · $223 in 2025
The $223 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $433 · 2020: $55.99 · 2021: $73.75 · 2022: $147 · 2023: $418 · 2024: $223 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $863.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $266.75 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $145.01 | 2019-2022 | |
| Amgen INC. | $116.17 | 2019-2023 | Evenity, Prolia |
| Vertex Pharmaceuticals Incorporated | $102.29 | 2024-2025 | |
| Pacira Therapeutics, INC. | $87.24 | 2019 | |
| Ferring Pharmaceuticals INC. | $80.70 | 2022-2025 | Euflexxa |
| Averitas Pharma INC. | $73.00 | 2023-2024 | Qutenza |
| Convatec INC. | $55.03 | 2019-2025 | |
| Avanos Medical | $53.81 | 2025 | Generator |
| Djo, LLC | $53.73 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $51.61 | 2022-2024 | Exparel, Iovera, Zilretta |
| Polynovo North America LLC | $44.66 | 2021-2024 | Novosorb Btm |
| Astrazeneca Pharmaceuticals LP | $34.85 | 2023 | Andexxa |
| Checkpoint Surgical, INC | $32.76 | 2023 | Checkpoint Stimulators |
| Zimmer Biomet Holdings, INC. | $31.41 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $31.14 | 2019 | |
| Paratek Pharmaceuticals, INC. | $28.87 | 2021-2023 | Nuzyra |
| Pfizer INC. | $26.77 | 2019-2025 | |
| My01 INC. | $22.42 | 2023 | My01 Continuous Compartmental Pressure Monitor |
| Alexion Pharmaceuticals, INC. | $21.29 | 2022 | |
| Blue Surgical LLC | $19.47 | 2025 | |
| Csl Behring | $19.42 | 2022 | |
| Baxter Healthcare | $18.37 | 2025 | Perclot |
| Davol INC. | $17.88 | 2023 | Channel Drain |
| Kowa Pharmaceuticals America, INC. | $17.48 | 2023 | Seglentis |
| Orthogenrx INC. | $17.27 | 2019 | |
| Axogen | $17.20 | 2019 | |
| Kls-Martin L.P. | $15.16 | 2024 | |
| Si-Bone, INC. | $14.88 | 2023 | |
| Kci USA, INC. | $14.79 | 2022 | |
| Heron Therapeutics, INC. | $14.78 | 2024 | Zynrelef |
| Melinta Therapeutics, LLC | $13.64 | 2019 | |
| Grt US Holding, INC. | $12.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Varney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.